Real-World Clinical Experience of Rosuvastatin as a Lipid-Lowering Therapy for Primary and Secondary Prevention of Cardiovascular Events (REAL ROSE)

Background Rosuvastatin effectively reduces endogenous cholesterol synthesis and low-density lipoprotein (LDL) cholesterol and increases high-density lipoprotein (HDL) cholesterol. This study aimed to evaluate the clinical characteristics of patients and treatment patterns of rosuvastatin as a lipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Ashwani, Jain, Pradeep, Patil, Ravikant, Sashi Kant, T, Indurkar, Sanjiv A, Kota, Sunil Kumar, Revankar, Santosh, Gupta, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748627/
https://www.ncbi.nlm.nih.gov/pubmed/36523717
http://dx.doi.org/10.7759/cureus.31468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748627/
https://www.ncbi.nlm.nih.gov/pubmed/36523717
http://dx.doi.org/10.7759/cureus.31468

Ejemplares similares